Relmada Therapeutics, Inc. (RLMD)

7.05 -0.09 (-1.26%) USD  |  NASDAQ  |  Apr 22, 16:00
7.05 0.00 (0.00%) After-Hours: 18:10
More

Relmada Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade